Anticoagulation with VADs and ECMO: walking the tightrope

Area of Science:

• Biomedical Engineering
• Cardiovascular Medicine
• Hematology

Background:

• Mechanical circulatory support (MCS) devices, including ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO), are vital for critically ill patients with cardiac or respiratory failure.
• These complex devices bypass the heart or lungs, but disrupt normal hemostasis, leading to a high risk of thrombosis and bleeding.
• Anticoagulation is essential to prevent device failure and embolic events, yet balancing this with bleeding risk is a significant clinical challenge.

Purpose of the Study:

• To review the current challenges and considerations in managing antithrombotic therapy for patients requiring mechanical circulatory support.
• To highlight the need for improved device design and individualized antithrombotic strategies.
• To emphasize the importance of balancing anticoagulation for thrombosis prevention against the high risk of bleeding in MCS patients.

Main Methods:

• Review of existing literature on mechanical circulatory support devices and antithrombotic therapy.
• Analysis of factors influencing hemostasis and thrombotic/hemorrhagic complications in MCS patients.
• Discussion of current clinical practices and areas for future research.

Main Results:

• Patients on MCS face a delicate balance between preventing device-related thrombosis and managing high bleeding rates.
• Significant variability exists in current anticoagulant and antiplatelet approaches due to limited high-quality data.
• Both patient-specific factors and device characteristics influence the optimal antithrombotic strategy.

Conclusions:

• Improvements in MCS device design and manufacturing are expected to enhance patient outcomes.
• Individualized titration of antithrombotic therapy is crucial for optimizing the balance between thrombotic and hemorrhagic risks.
• Further research is needed to establish evidence-based guidelines for antithrombotic management in MCS patients.